Amicus Therapeutics, Inc. (FOLD): Price and Financial Metrics


Amicus Therapeutics, Inc. (FOLD)

Today's Latest Price: $8.37 USD

0.07 (-0.83%)

Updated Oct 23 4:00pm

Add FOLD to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 328 in Biotech

See all "A" rated Strong Buy stocks

FOLD Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for FOLD is 0.22 -- better than just 16.34% of US stocks.
  • FOLD's price/sales ratio is 15.81; that's higher than the P/S ratio of 93.44% of US stocks.
  • Revenue growth over the past 12 months for Amicus Therapeutics Inc comes in at 106.6%, a number that bests 94.88% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Amicus Therapeutics Inc are AVEO, NOVN, GSIT, ELTP, and CAPR.
  • Visit FOLD's SEC page to see the company's official filings. To visit the company's web site, go to www.amicusrx.com.
FOLD Daily Price Range
FOLD 52-Week Price Range

FOLD Stock Price Chart More Charts


FOLD Price/Volume Stats

Current price $8.37
Prev. close $8.44
Day low $8.34
Day high $8.58
50-day MA $9.08
200-day MA $11.61
52-week high $14.61
52-week low $7.11
Volume 2,246,800
Avg. volume 3,366,077
Dividend yield N/A
Market Cap 2.13B

Amicus Therapeutics, Inc. (FOLD) Company Bio


Amicus Therapeutics is developing treatments for a broad range of human genetic diseases, with a focus on delivering new benefits to individuals with lysosomal storage disorders. The company was founded in 2002 and is based in Cranbury, New Jersey.





FOLD Latest News Stream


Event/Time News Detail
Loading, please wait...

FOLD Latest Social Stream


Loading social stream, please wait...

View Full FOLD Social Stream

FOLD Price Returns

1-mo -8.22%
3-mo -33.09%
6-mo -37.77%
1-year -26.77%
3-year 12.05%
5-year 40.91%
YTD -12.63%
2018 -33.43%
2017 189.54%
2016 -48.76%
2015 16.59%
2014 254.04%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7361 seconds.